---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-274634"
form_type: "8-K"
ticker: "CSTL"
cik: "0001447362"
company_name: "CASTLE BIOSCIENCES INC"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:26:26.188343+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Castle Biosciences adopts Severance and Change in Control Plan for top executives

## Summary
- Plan adopted Nov 3, 2023; covers CEO Maetzold, CFO Stokes, CCO Juvenal, COO Oelschlager.
- On CIC termination: CEO gets 36 months salary + 300% target bonus; others get 12 months salary + prior year bonus.
- On non-CIC termination: CEO gets 18 months salary + 150% target bonus; others get 12 months salary + 100% target bonus.
- Equity acceleration: 100% on CIC termination; pro-rata for 12/18 months on non-CIC termination.
- Plan replaces prior severance benefits under employment agreements.

## SEC filing metadata
- accession: 0001193125-23-274634
- form_type: 8-K
- ticker: CSTL
- cik: 0001447362
- company_name: CASTLE BIOSCIENCES INC
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/0001193125-23-274634-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/d530518d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-274634
- JSON: https://secwatch.observer/filing/0001193125-23-274634.json
- Plain text: https://secwatch.observer/filing/0001193125-23-274634.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.